Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Denali Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DNLI.
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Ascentage Pharma Group (NASDAQ:AAPG) and SpringWorks Therapeutics (NASDAQ:SWTX).
Denali Therapeutics has a consensus price target of $38.79.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $16.6 last updated April 30, 2025 at 3:34 PM EDT.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.